The company said its profits were mostly brought down in its U.K. business and because of increased sales of low-margin items, higher supply chain costs and higher expenses for labor and store cleaning.
Walgreens shares were down nearly 7 percent the morning of July 9, according to CNBC.
The company said it would cut more than 4,000 jobs in the U.K. and shut 48 optician centers there.
Its third quarter earnings per share were 83 cents versus an expected $1.17, but revenue was slightly higher than expected, at $34.63 billion versus $34.36 billion.
Walgreens posted a net loss of $1.71 billion in the third quarter, CNBC reported.
At U.S. stores that have been open at least a year, sales rose 3 percent over last year. Same-store pharmacy sales also rose 3.5 percent over last year. Walgreens said brand inflation and an increase in specialty sales offset the drop in prescription volumes caused by COVID-19.
Same-store retail sales also grew by 1.9 percent in the third quarter due to strong demand for vitamins and protective equipment, such as masks, CNBC reported.
Read the full article here.
More articles on pharmacy:
More drugmakers recall metformin products after finding they contain carcinogen
12 key trends in hospital pharmacy from the ASHP annual survey
Sandoz to supply Civica Rx with 6 injectable drugs
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.